Intuitive Surgical, Inc.
General ticker "ISRG" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $185.1B (TTM average)
Intuitive Surgical, Inc. follows the US Stock Market performance with the rate: 21.7%.
Estimated limits based on current volatility of 1.5%: low 460.61$, high 474.32$
Factors to consider:
- Earnings expected soon, date: 2026-04-28 amc
- Company included in S&P500 list
- Company included in NASDAQ-100 index
- Total employees count: 15638 (+14.3%) as of 2024
- US accounted for 43.4% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Litigation risks, Liquidity and credit risks, Supply chain disruptions, Manufacturing delays and scale, Economic downturns and volatility
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [491.51$, 646.19$]
- 2026-12-31 to 2027-12-31 estimated range: [545.95$, 708.13$]
Financial Metrics affecting the ISRG estimates:
- Negative: with PPE of 64.0 at the end of fiscal year the price was high
- Positive: Operating profit margin, % of 29.27 > 18.52
- Positive: Shareholder equity ratio, % of 86.39 > 64.25
- Negative: Industry inventory ratio change (median), % of 0.78 > 0.31
- Negative: Inventory ratio change, % of 0.83 > 0.80
- Positive: 0.07 < Operating cash flow per share per price, % of 1.49
Short-term ISRG quotes
Relationship graph
Long-term ISRG plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $7,124.10MM | $8,352.10MM | $10,064.70MM |
| Operating Expenses | $5,357.30MM | $6,003.20MM | $7,119.20MM |
| Operating Income | $1,766.80MM | $2,348.90MM | $2,945.50MM |
| Non-Operating Income | $192.10MM | $324.90MM | $365.90MM |
| R&D Expense | $998.80MM | $1,145.30MM | $1,311.80MM |
| Income(Loss) | $1,958.90MM | $2,673.80MM | $3,311.40MM |
| Taxes | $141.60MM | $336.30MM | $434.80MM |
| Profit(Loss)* | $1,798.00MM | $2,322.60MM | $2,856.00MM |
| Stockholders Equity | $13,307.60MM | $16,433.70MM | $17,824.00MM |
| Inventory | $1,220.60MM | $1,487.20MM | $1,840.00MM |
| Assets | $15,441.50MM | $18,743.20MM | $20,631.20MM |
| Operating Cash Flow | $1,813.80MM | $2,415.00MM | $3,030.50MM |
| Capital expenditure | $1,064.20MM | $1,111.20MM | $539.80MM |
| Investing Cash Flow | $-360.10MM | $-3,272.80MM | $665.80MM |
| Financing Cash Flow | $-287.60MM | $150.90MM | $-2,364.10MM |
| Earnings Per Share** | $5.12 | $6.54 | $8.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.